Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Differences in the Majeed Pelvic Score Between Injured and Uninjured Patients

Brouwers, Lars, MD, MSc*; Wouter Lansink, Koen Willem, MD, PhD*,†; van Delft-Schreurs, Katinka, MSc*; Cornelia de Jongh, Mariska Adriana, PhD*

Journal of Orthopaedic Trauma: May 2019 - Volume 33 - Issue 5 - p 244–249
doi: 10.1097/BOT.0000000000001428
Original Article
Buy
SDC

Objectives: To investigate the differences in the Majeed Pelvic Score (MPS) between injured and uninjured patients. Discriminative power and applicability of the MPS in elderly are also investigated, and a norm score for the MPS in the Netherlands is provided.

Design: Cross-sectional cohort study.

Setting: Urban level 1 trauma center.

Patients/Participants: One hundred ninety-five patients with pelvic ring disruptions; 101 61A, 67 61B, and 27 61C (OTA/AO classification; 6%, 27%, and 82% surgically treated, respectively); mean follow-up 29 months (range 6–61); 554 adults from the Longitudinal Internet Studies for the Social Sciences panel (control group). Participants were divided into 2 age groups: <65 and ≥65 years (respectively, maximum MPS: 100 and 80 points).

Main Outcome Measurements: Majeed Pelvic Score.

Results: Patients <65 years of age (81.6) scored lower on the MPS when compared with the control group (88.3, P < 0.001). Patients ≥65 years of age (68.1) scored lower on the MPS when compared with the control group (72.0, P = 0.006). In the <65 group, the patient group scored worse on the sexual function, work, and standing dimensions (P < 0.001). In the ≥65 group, the patient group scored worse on the dimensions sitting (P = 0.03) and standing (P < 0.001) and better on the dimension pain (P = 0.001).

Conclusions: Compared with the general population, patients with pelvic ring disruption in both age groups perceived some health problems in almost all MPS domains. The MPS discriminates well enough to provide information about the mobility of elderly patients.

Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

*Brabant Trauma Registry, Network Emergency Care Brabant, Tilburg, the Netherlands; and

Department of Surgery, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.

Reprints: Lars Brouwers, MD, MSc, Network Emergency Care Brabant, Elisabeth-Tweesteden Hospital, Postbus 90151, 5000 LC Tilburg, The Netherlands (e-mail: l.brouwers@etz.nl).

The authors report no conflict of interest.

Accepted December 12, 2018

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.